Corporate Board Profile
| Filing Date | Source Excerpt |
|---|---|
| 2021-04-30 | Dr. Doogan has over 30 years of industry experience in both major pharma and biotech. |
| 2022-04-28 | Dr. Doogan received his medical degree from Glasgow University. |
| 2023-04-28 | Dr. Doogan served as Chief Executive Officer of Portage Biotech, Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company. |
| 2023-10-27 | ...Declan Doogan, MD...* Less than 1%... |
| 2024-04-26 | Dr. Doogan served as Chief Executive Officer of Portage Biotech, Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company. |
| 2024-09-27 | Declan Doogan, MD 48,500 |
Data sourced from SEC filings. Last updated: 2025-04-15